Altogether, members of the specialty collected nearly 5,800 of these payments in 2024, from sources such as pharmaceutical companies and imaging device manufacturers.
Medmo and Covera Health, both based in New York, officially announced their merger on April 21, with the latter’s lead investor, Insight Partners, funding the deal.
Speaking at a Politico health care policy forum, CMS Administrator Mehmet Oz, MD, said he supports Medicaid, adding that “when you love something, you protect it.”
The insurance giant has been piloting a program to speed up reimbursement to hospitals in 10 states, reducing delays by roughly 50%. Now, the company said it will work to lift prior authorization barriers on patient care delivery. The intent is to roll out these changes nationwide by the end of 2026, UnitedHealthcare confirmed.
By and large, U.S. hospitals and health systems do not have an AI adoption problem. But many—if not most—have an execution problem: They struggle to turn a set of installed AI tools into a measurable operational value.
Family physicians and other primary care providers don’t mind being held to account for care quality by healthcare administrators. The rub is that multiple other stakeholders often demand similar levels of answerability, pulling the doctors in different directions at once.
Developed by a board-certified diagnostic and interventional radiologist, the platform was trained using subspecialty data that general AI applications typically lack.
Researchers at the University of Florida College of Medicine say mRNA technology could "educate" the immune system to identify and attack cancer anywhere in the body. A promising proof-of-concept study using mice was published in Nature Biomedical Engineering.
Ritesh Kalra, MD, allegedly wrote 31,000 opioid prescriptions between 2019 and 2025, many of which were illegitimate. He is accused of inappropriately touching patients in exchange for oxycodone scripts as part of a five-count criminal indictment.
A problem with the B/V filters on SunMed adult resuscitators can cause the devices to malfunction. Due to the high safety risk this poses to patients, the FDA has assigned this recall its most serious designation.
Altogether, members of the specialty collected nearly 5,800 of these payments in 2024, from sources such as pharmaceutical companies and imaging device manufacturers.
